A strategy with label-free quantification of the targeted peptides for quantitative peptidome analysis of human serum

Science China Chemistry

Volumn 53, Issue 4, 2010, Pages 759-767

  Zhu, Jun ^a,b,c   Wang, Fang Jun ^a,b,c   Dong, Xiao Li ^a,b,c   Ye, Ming Liang ^a,b,c   Zou, Han Fa ^a,b,c  

^a Key Laboratory of Separation Sciences for Analytical Chemistry   (China)

^b National Chromatographic Research and Analysis Center   (China)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Breast cancer; Hepatocellular carcinoma; Human serum; Label free quantification; Peptidomics

Indexed keywords

BREAST CANCER; HEPATOCELLULAR CARCINOMA; HUMAN SERUM; LABEL FREE; PEPTIDOMICS;

BODY FLUIDS; DIAGNOSIS; LABELS;

PEPTIDES;

EID: 77953299282     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-010-0127-7     Document Type: Article

References (42)

1. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003, 3: 267-275 (Pubitemid 37328862)
2. Chung CH, Levy S, Chaurand P, Carbone DP. Genomics and proteomics: emerging technologies in clinical cancer research. Crit Rev Oncol Hematol, 2007, 61: 1-25 (Pubitemid 44880146)
3. Bermúdez-Crespo J, López JL. A better understanding of molecular mechanisms underlying human disease. Proteomics Clin Appl, 2007, 1: 983-1003
4. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP. Proteomic patterns of tumour subsets in non-smallcell lung cancer. Lancet, 2003, 362: 433-439 (Pubitemid 36999706)
5. Schrader M, Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol, 2001, 19 (Suppl): S55-S60
6. Soloviev M, Finch P. Peptidomics: bridging the gap between proteomeand metabolome. Proteomics, 2006, 6: 744-747 (Pubitemid 43260199)
7. Diamandis EP. Peptidomics for cancer diagnosis: present and future. J Proteome Res, 2006, 5: 2079-2082 (Pubitemid 44330798)
8. Bischoff R, Luider TM. Methodological advances in the discovery of protein and peptide disease markers. J Chromatogr B, 2004, 803: 27-40 (Pubitemid 38340636)
9. Ahn S, Simpson RJ. Body fluid proteomics: prospects for biomarker discovery. Proteomics Clin Appl, 2007, 1: 1004-1015
10. Villanueva J, Lawlor K, Toledo-Crow R, Tempst P. Automated serum peptide profiling. Nat Protoc, 2006, 1: 880-891
11. Villanueva J, Philip J, DeNoyer L, Tempst P. Data analysis of assorted serum peptidome profiles. Nat Protoc, 2007, 2: 588-602 (Pubitemid 47040021)
12. Rosenzweig CN, Zhang Z, Sun X, Sokoll LJ, Osborne K, Partin AW, Chan DW. Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers. J Urology, 2009, 181: 1407-1414
13. Wang N, Wen X, Wang J, Li A, Li W, Li T, Li Y, Zhang X, Wang H, Yang S, Zhou T, Gong W, Tian Y, He K. Breast cancer-specific serum peptide profiles. Chin Sci Bull, 2009, 54(3): 421-429
14. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol, 1999, 17: 676-682 (Pubitemid 29316146)
15. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol, 2001, 19: 242-247 (Pubitemid 32220565)
16. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359: 572-577 (Pubitemid 34178440)
17. Villanueva J, Schaffer DR, Phillip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lijia H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst PJ. Differential exoprotease activities confer tumor-specific serum peptidome patterns. Clin Invest, 2006, 116: 271-284 (Pubitemid 43121812)
18. Koomen JM, Li D, Xiao L, Liu TC, Coombes KR, Abbruzzese J, Kobayashi R. Direct tandem mass spectrometry reveals limitations protein profiling experiments for plasma biomarker discovery. J Proteome Res, 2005, 4: 972-981 (Pubitemid 40863287)
19. Chang WC, Huang LCL, Wang Y, Peng W, Chang HC, Hsu NY, Yang WB, Chen CH. Matrix-assisted laser desorption/ionization (MALDI) mechanism revisited. Anal Chim Acta, 2007, 582: 1-9 (Pubitemid 44880902)
20. Uttenweiler-Joseph S, Moniatte M, Lagueux M, Dorsselaer AV, Hoffmann JA, Bulet P. Differential display of peptides induced during the immune response of drosophila: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study. Proc Natl Acad Sci USA, 1998, 95: 11342-11347 (Pubitemid 28450130)
21. Jiménez CR, Dreisewerd K, Mansvelder HD, Brussaard AB, Reinhold BB, Van der Schors RC, Karas M, Hillenkamp F, Burbach JPH, Costello CE, Geraerts WPM. Pattern changes of pituitary peptides in rat after salt-loading as detected by means of direct, semiquantitative mass spectrometric profiling. Proc Natl Acad Sci USA, 1997, 94: 9481-9486 (Pubitemid 27357855)
22. Hu LH, Zhou HJ, Li YH, Sun ST, Guo LH, Ye ML, Tian XF, Gu JR, Yang SL, Zou HF. Profiling of endogenous serum phosphorylated peptides by titanium (IV) immobilized mesoporous silica particles enrichment and MALDI-TOFMS detection. Anal Chem, 2009, 81(1): 94-104
23. Wang GH, Wu WW, Zeng WH, Chou CL, Shen RF. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J Proteome Res, 2006, 5: 1214-1223
24. Wang W, Zhou H, Lin H, Roy S, Shaler TA, Hill LR, Norton S, Kumar P, Anderle M, Becker CH. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem, 2003, 75: 4818-4826 (Pubitemid 37139783)
25. Radulovic D, Jelveh S, Ryu S, Hamilton G, Foss E, Mao Y, Emili A. Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics, 2004, 3: 984-997 (Pubitemid 40361233)
26. Prakash A, Piening B, Whiteaker J, Zhang H, Shaffer SA, Martin D, Hohmann L, Cooke K, Olson JM, Hansen S, Flory MR, Lee H, Watts J, Goodlett DR, Aebersold R, Paulovich A, Schwikowski B. Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomics. Mol Cell Proteomics, 2007, 6: 1741-1748 (Pubitemid 350031675)
27. Quintana LF, Campistol JM, Alcolea MP, Banon-Maneus Solé- González A, Cutillas PR. Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics, 2009, 8: 1658-1673
28. Silva JC, Denny R, Dorschel CA, Gorenstein M, Kass IJ, Li GZ, Mckenna T, Nold MJ, Richardson K, Young P, Geromanos S. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem, 2005, 77: 2187-2200 (Pubitemid 40463836)
29. Purvine S, Eppel JT, Yi EC, Goodlett DR. Shotgun collision-induced dissociation of peptides using a time of flight mass analyzer. Proteomics, 2003, 3: 847-850 (Pubitemid 36801670)
30. Hughes MA, Silva JC, Geromanos SJ, Townsend CA. Quantitative proteomic analysis of drug-induced changes in mycobacteria. J Proteome Res, 2006, 5: 54-63 (Pubitemid 43100797)
31. Silva JC, Gorenstein MV, Li GZ, Vissers JPC, Geromanos SJ. Absolute quantification of proteins by lcmse: a virtue of parallel ms acquisition. Mol Cell Proteomics, 2006, 5: 144-156
32. Silva JC, Denny R, Dorschel C, Gorenstein MV, Li GZ, Richardson K, Wall D, Geromanos SJ. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome. Mol Cell Proteomics, 2006, 5: 589-607
33. Vissers JPC, Langridge JI, Aerts JMFG, Gerom. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics, 2007, 6: 755-766
34. Levin Y, Schwarz E, Wang L, Leweke FM, Bahn S. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J Sep Sci, 2007, 30: 2190-2197 (Pubitemid 47497019)
35. Tian RJ, Zhang H, Ye ML, Jiang XG, Hu LH, Li X, Bao XH, Zou HF. Selective extraction of peptides from human plasma by highly ordered mesoporous silica particles for peptidome analysis. Angew Chem Int Ed, 2007, 46: 962-965 (Pubitemid 46192058)
36. Tian RJ, Ren LB, Ma HJ, Li X, Hu LH, Ye ML, Wu RA, Tian ZJ, Liu Z, Zou HF. Selective enrichment of endogenous peptides by chemically modified porous nanoparticles for peptidome analysis. J Chromatogr A, 2009, 1216: 1270-1278
37. Wang FJ, Ye ML, Dong J, Tian RJ, Hu LH, Han GH, Jiang XN, Wu RA, Zou HF. Improvement of performance in label-free quantitative proteome analysis with monolithic electrospray ionization emitter. J Sep Sci, 2008, 31: 2589-2597
38. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res, 2005, 96: 1221-1232 (Pubitemid 40962099)
39. Phillips GB. The lipid composition of serum in patients with liver disease. J Clin Invest, 1960, 39: 1639-1650
40. Matsuura T, Koga S, Ibayashi H. Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis. Gastroenterol Jpn, 1988, 23(4): 394-400
41. Jiang JT, Nilsson-Ehle P, Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis, 2006, 5: 4
42. Hamm A, Veeck J, Bektas N, Wild PJ, Hartmann A, Heindrichs U, Kristiansen G, Werbowetski-Ogilvie T, Del Maestro R, Knuechel R, Dahl E. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 2008, 8: 25 (Pubitemid 351425946)